ATE262918T1 - Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie - Google Patents

Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie

Info

Publication number
ATE262918T1
ATE262918T1 AT00962987T AT00962987T ATE262918T1 AT E262918 T1 ATE262918 T1 AT E262918T1 AT 00962987 T AT00962987 T AT 00962987T AT 00962987 T AT00962987 T AT 00962987T AT E262918 T1 ATE262918 T1 AT E262918T1
Authority
AT
Austria
Prior art keywords
sternotomy
sternum
agent
medication
production
Prior art date
Application number
AT00962987T
Other languages
English (en)
Inventor
Masashi Komeda
Yasuhiko Tabata
Original Assignee
Kaken Pharma Co Ltd
Masashi Komeda
Yasuhiko Tabata
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharma Co Ltd, Masashi Komeda, Yasuhiko Tabata filed Critical Kaken Pharma Co Ltd
Application granted granted Critical
Publication of ATE262918T1 publication Critical patent/ATE262918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AT00962987T 1999-09-30 2000-09-29 Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie ATE262918T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40880499A 1999-09-30 1999-09-30
PCT/JP2000/006781 WO2001022989A2 (en) 1999-09-30 2000-09-29 Method to enhance healing of sternum after sternotomy

Publications (1)

Publication Number Publication Date
ATE262918T1 true ATE262918T1 (de) 2004-04-15

Family

ID=23617831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00962987T ATE262918T1 (de) 1999-09-30 2000-09-29 Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie

Country Status (10)

Country Link
US (1) US6732738B1 (de)
EP (1) EP1218026B1 (de)
JP (1) JP4657549B2 (de)
KR (1) KR100689250B1 (de)
CN (1) CN1180841C (de)
AT (1) ATE262918T1 (de)
AU (1) AU7449500A (de)
CA (1) CA2385498C (de)
DE (1) DE60009525T2 (de)
WO (1) WO2001022989A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175656A1 (en) * 2000-09-05 2003-09-18 Erella Livne Hydrogel incorporated with bone growth promoting agents for dental and oral surgery
JP4878730B2 (ja) * 2001-07-18 2012-02-15 株式会社メドジェル Ｈｇｆヒドロゲル徐放性製剤
JP2004123576A (ja) * 2002-09-30 2004-04-22 Medgel Corp 多血小板血漿を含有する徐放性製剤
WO2004089400A1 (ja) * 2003-04-01 2004-10-21 Yasuhiko Tabata 心筋症治療剤
JP2005211477A (ja) * 2004-01-30 2005-08-11 Gunze Ltd 再生医療用支持体
US7361179B2 (en) 2004-04-22 2008-04-22 Ethicon, Inc. Sternal closure device and method
WO2009052221A2 (en) * 2007-10-15 2009-04-23 The Regents Of The University Of Colorado Methods for extracting platelets and compositions obtained therefrom

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2048673A1 (en) * 1989-03-07 1990-09-08 Donald Metcalf Metabolic effects of leukaemia inhibitory factor on bone
JP3135138B2 (ja) 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
EP0499242B1 (de) * 1991-02-15 1996-06-26 Takeda Chemical Industries, Ltd. Mit einem Zellwachstumsfaktor bewirkte Anregung von Wachstum im Knocheninneren
JPH05132426A (ja) * 1991-02-15 1993-05-28 Takeda Chem Ind Ltd 骨組織の形成促進剤
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
DE69427908T2 (de) * 1993-05-31 2001-11-22 Kaken Pharma Co Ltd Eine gelpräparation aus vernetzter gelatine, die einen basischen wachstumsfaktor für fibroblasten enthält
US5755682A (en) * 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
BR9712348B1 (pt) * 1996-10-16 2013-06-18 vetor de expressão, célula de bactéria ou levedura transformada ou transfectada, processo para produzir um polipeptídeo homólogo de fgf, composição farmacêutica, e, processos para estimular ex vivo células progenitoras de miócitos ou miócitos
US6123731A (en) * 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture
US6294187B1 (en) * 1999-02-23 2001-09-25 Osteotech, Inc. Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
US6478825B1 (en) * 2001-11-28 2002-11-12 Osteotech, Inc. Implant, method of making same and use of the implant for the treatment of bone defects

Also Published As

Publication number Publication date
JP2003510289A (ja) 2003-03-18
CA2385498C (en) 2013-01-08
CN1180841C (zh) 2004-12-22
DE60009525D1 (de) 2004-05-06
JP4657549B2 (ja) 2011-03-23
WO2001022989A2 (en) 2001-04-05
CN1382058A (zh) 2002-11-27
WO2001022989A3 (en) 2001-08-23
EP1218026A2 (de) 2002-07-03
AU7449500A (en) 2001-04-30
EP1218026B1 (de) 2004-03-31
DE60009525T2 (de) 2005-02-03
CA2385498A1 (en) 2001-04-05
KR100689250B1 (ko) 2007-03-08
KR20020040828A (ko) 2002-05-30
US6732738B1 (en) 2004-05-11

Similar Documents

Publication Publication Date Title
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
BR0014767A (pt) Fibras de sementes de plantas e uso
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
NO20063667L (no) Anvendelse av et anti-mikrotubulimiddel for fremstilling av en farmasoytisk blanding for behandling eller forhindring av kirurgiske adhesjoner
BR0016957A (pt) Enxerto arterial-venoso com sistema de distribuição de droga(s) e processo para o tratamento de eventos biológicos sequênciais que ocorrem em resposta à implantação de um enxerto e sistema de ministração de drogas
DE50214266D1 (de) Verfahren zur hemmung der expression eines zielgens und medikament zur therapie einer tumorerkrankung
PT101447A (pt) Processo para a preparacao de uma solucao sobressaturada de um soluto inorganico num dissolvente aquoso, solucao preparada de acordo com o processo e processo para o tratamento da madeira por impregnacao com a referida solucao
DK0968723T3 (da) Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor
ATE262918T1 (de) Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie
FI943028A (fi) Happoa kestävä FGF-koostumus ja menetelmä ruoansulatuskanavassa esiintyvien, haavaumia aiheuttavien sairauksien hoitamiseksi
BR0213100A (pt) Combinações para o tratamento de distúrbios imuniinflamatórios
ATE140382T1 (de) Haarpflegemittel
DK0462194T3 (da) Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger
DE69937615D1 (de) Mittel zur Behandlung von Gewebe welches Wasser abweist und das Gewebe selbst
WO2021195470A3 (en) Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2
WO2003030780A3 (en) Method and apparatus for performing an anastamosis
FI904403A0 (fi) Fettsyrabehandling.
DE69920015D1 (de) Verfahren zur induktion der herstellung von wachstumsfaktoren
BR0013416A (pt) Droga, uso de uma droga selecionada do grupo que consiste de pelo menos um bisfosfonato, e, método para tratamento de um osso fraturado
ES2061021T3 (es) Tratamiento de la dependencia de ventilador con hormona del crecimiento.
FI951759A0 (fi) Menetelmä 2,2-difluoriketeenisilyyli-O,S-asetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihapon O,S-estereiden valmistamiseksi
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
ATE297211T1 (de) Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen
ES2018207B3 (es) Un agente para el tratamiento de superficies y proceso para la produccion del mismo.
DK0968174T3 (da) Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties